Thus, Trabid deficiency in tumors suppresses tumor growth and induces an anti-tumor immune microenvironment by increasing the intratumoral infiltration of anti-tumor immune cells and decreasing that of pro-tumor immune cells. Here, ZRANB1 is linked to neoplasm.